| The
effectiveness of different classes of hypertension drugs depends on the time of
the day they are taken and treatment strategies should be considered accordingly,
according to a study reported in the January issue of the American Journal of
Hypertension. "This
study recognizes the growing importance of time of day when a person should take
his or her hypertension medication to achieve the drug's maximum effect,"
said Dr. Michael A. Weber, an editor of the American Journal of Hypertension.
"Timed administration of medication is going to play a greater role in treating
hypertension since blood pressure rises and falls throughout the day." "Blood
pressure is controlled by a large number of variables," concluded researchers
from the University of Melbourne in Australia. "We recognize this by the
individual variation that occurs in response to specific drugs. The evidence from
this study that different drugs work more effectively at different times of the
day may require us to rethink our therapeutic strategies." Researchers
found that hydrochlorothiazide diuretics and the calcium channel blocker felodopine
were more consistent over 24-hours than the beta-blocker atenolol and the angiotensin
converting enzyme (ACE) inhibitor perindopril. The
study involved 24 patients over the age 65 with untreated systolic hypertension.
Each patient received four different treatments and a placebo for eight weeks
and wore an ambulatory blood pressure monitor to record blood pressure during
the day and at night. The
researchers found that ACE inhibitors caused a larger fall in blood pressure while
patients slept than when they were awake, while beta blocking drugs had a smaller
and insignificant effect during sleep. The diuretic and the calcium channel blocker
appeared to have a relatively consistent effect on blood pressure. "The
responses to atenolol (beta blocker) and perindopril (ACE inhibitor) were highly
dependent on the time of day," the researchers said. "The greater effectiveness
of ACE inhibitors at night may explain in part their greater effectiveness at
reducing cardiac hypertrophy and coronary artery deaths." American
Journal of Hypertension: January 2003; 16:46-50
|